Immunic, Inc.
IMUX
$0.72
-$0.0264-3.54%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.18% | -3.31% | -13.98% | 27.73% | -37.14% |
| Total Depreciation and Amortization | 22.86% | -16.67% | 35.48% | 19.23% | 13.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.52% | 7.12% | 40.93% | -85.70% | 573.15% |
| Change in Net Operating Assets | 2,095.77% | -95.44% | -46.73% | 170.18% | -168.58% |
| Cash from Operations | 5.17% | -10.38% | -22.15% | 28.95% | -70.88% |
| Capital Expenditure | -1,466.67% | 94.00% | 72.22% | -480.65% | 81.21% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,466.67% | 94.00% | 72.22% | -480.65% | 81.21% |
| Total Debt Issued | -- | -- | -- | -100.00% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -68.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | 12,228.48% |
| Foreign Exchange rate Adjustments | 189.30% | -327.43% | 156.08% | -331.61% | -69.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.71% | -13.46% | -17.11% | -134.78% | 489.07% |